Navigation Links
Sandia seeks commercial partners for revolutionary 'SpinDx' medical diagnostic tool
Date:7/12/2012

LIVERMORE, Calif. Researchers at Sandia National Laboratories have developed a lab-on-a-disk platform that they believe will be faster, less expensive and more versatile than similar medical diagnostic tools.

Lab officials are seeking industry partners to license and commercialize the SpinDx technology, which can determine a patient's white blood cell count, analyze important protein markers, and process up to 64 assays from a single sample, all in a matter of minutes.

"In a doctor's office, time is money," said Anup Singh, manager of Sandia's biotechnology and bioengineering department. "Patients have become accustomed to an initial visit, some tests, samples that are sent off to a far-away lab, a wait of a week or more for results, more tests and charges every step of the way. With SpinDx, you can see results before you even leave the office."

(Visit www.youtube.com/SandiaLabs to view HD video footage of the "SpinDx" medical diagnostic tool)

The technology advances in SpinDx have profound implications for patient care. Heart attacks, strokes, infections, certain cancers and other afflictions could be detected days or weeks sooner than they are today, with no new burdens placed on patients or their doctors, Singh said.

The SpinDx platform has several advantages:

  • Small sample size: Patients merely have to provide a pin-prick sample of blood.
  • Ease of use: The device uses a spinning disk, much like a CD player, to manipulate a sample. The disks contain commercially available reagents and antibodies specific to each protein marker.
  • Custom applications: Singh envisions a "plug and play" approach whereby the physician chooses among a "cardiac disk," "immune disk" and similar options.
  • Inexpensive technology: The disks the crux of the technology cost pennies to manufacture.
  • Quick response time: Results can b
    '/>"/>

Contact: Mike Janes
mejanes@sandia.gov
925-294-2447
DOE/Sandia National Laboratories
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Miniature Sandia sensors may advance climate studies
2. Trial seeks improved lung-cancer screening by combining imaging and biomarkers
3. Researchers take hibiscus efforts to commercialization
4. A study confirms that long commercials evoke stronger emotions
5. Kessler Foundation implements Ekso Bionics first commercial robotic exoskeleton
6. F1000 Research partners with figshare to provide smart ways of accessing data
7. Royal Astronomical Society and Oxford University Press partnership announced
8. Grants add to Northwestern-Qatar partnership
9. New museum-university partnership ushers in new era of environmental science education
10. Ducks Unlimited Canada and Canadian Light Source partnership to shed light on wetlands
11. Science, Innovation, and Partnerships for Sustainability -- Symposium May 16-18
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sandia seeks commercial partners for revolutionary 'SpinDx' medical diagnostic tool
(Date:7/8/2015)... -- Summary Pancreatic cancer is the 12th most ... a mortality rate of 10.9 deaths per 100,000 people ... has highlighted a significant need for new and improved ... the current market. A highly active pancreatic cancer ... types and mechanisms of action, which provides a striking ...
(Date:7/8/2015)... Florida , July 8, 2015 ... evolving as this summer,s must have products such as wearables, ... demand as popularity for biometrics based devices continues to rapidly ... NXT-ID, Inc. (NASDAQ: NXTD ), Google Inc. (NASDAQ: ... (NYSE: FIT ), GoPro, Inc. (NASDAQ: GPRO ) ...
(Date:7/7/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") a ... a revised version of one of its first 30 second commercials ... in New York , Chicago ... Francisco metro areas.    , , , ... all the cards in your wallet and keep your identity secure. ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 4Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 5Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 6Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... resistance among Chesapeake Bay oysters calls for a shift in ... to a new study by researchers at the Virginia Institute ... Carnegie and Eugene Burreson, is the feature article in the ... It is based on 50 years of VIMS research into ...
... Inc., (OTCBB: CELO), (the "Company"), proudly announced today that ... Office. The patent, U.S. Patent Number 7,962,755 entitled "System ... provides the ability to biometrically enable encryption and decryption ... patent is unique in that it allows a user ...
... anti-retroviral drugs commonly used to treat HIV, particularly in ... according to research published today in the journal ... damage DNA in the patient,s mitochondria the ,batteries, ... why HIV-infected people treated with antiretroviral drugs sometimes show ...
Cached Biology News:Disease-resistant oysters call for shift in Bay restoration strategies 2Disease-resistant oysters call for shift in Bay restoration strategies 3Ceelox Vault Patent Issued 2Ceelox Vault Patent Issued 3Premature aging caused by some HIV drugs, study shows 2
(Date:7/29/2015)... 29, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... selected an optimized Erk inhibitor molecule for development, ... of a new class of potential cancer therapies. ... prime target for therapeutic intervention in cancer. Recently ... benefits for B-Raf and Mek inhibitors. Erk inhibitors ...
(Date:7/29/2015)... ... July 29, 2015 , ... Available in ... Express Contouring Bi-Gel, a nighttime-specific product that targets fat cells for extreme contouring ... able to enter fat cells, inhibiting the formation of new fat. Upon waking ...
(Date:7/29/2015)... ... July 29, 2015 , ... Asymmetrex, LLC ... in evaluating the full range of capabilities of its unique cache of technologies ... perform the day-to-day renewal and repair of normal tissues and organs. This property ...
(Date:7/28/2015)... ... July 29, 2015 , ... Strong Animals™ announced today that research conducted ... and presented at the ADSA-ASAS Joint Annual Meeting held July 12-16 in Orlando, FL ... and increased milk fat content. Also, feed containing Stay Strong™ for Dairy Cows took ...
Breaking Biology Technology:Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 2Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 3Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 2Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 3Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 4Strong Animals™ Announces South Dakota State University Research Demonstrates Stay Strong™ for Dairy Cows Improves Performance and Feed Stability 2
... Mass. and TORONTO, April 7, 2011  Generex Biotechnology ... this week there will be presentations of data ... Company,s proprietary buccal insulin spray product, at two ... The presentations, entitled "Use of Buccal Spray ...
... 7, 2011 The Center for Business Intelligence (CBI) announced ... Red Cross in support of the relief efforts in Japan ... contributions to the fund while the organization matched employee donations. ... generosity CBI employees have displayed to help a nation in ...
... Reportlinker.com announces that a new market research ... Industrial Biotechnology China News 1103 ... central government was reported to continue intensifying the ... Five-Year (2011-2015) Plan. This act is expected to ...
Cached Biology Technology:Generex Oral-lyn™ Data to be Presented at Two International Scientific Symposia 2Generex Oral-lyn™ Data to be Presented at Two International Scientific Symposia 3The Center for Business Intelligence Donates to the American Red Cross, Matching Employee Contributions for Disaster Relief in Japan 2Reportlinker Adds Industrial Biotechnology China News 1103 2Reportlinker Adds Industrial Biotechnology China News 1103 3
Mouse monoclonal [15-2] to Mannose Receptor (Biotin) ( Abpromise for all tested applications). entrezGeneID: 4360 SwissProtID: P22897...
... Immunogen: Peptide corresponding to ... mouse, and rat phospho-FAK (Ser843) ... Quality Assurance: ... Molecular Weight: ...
SAPK/JNK Antibody...
Mouse monoclonal [DJR3] to DcR1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798...
Biology Products: